EVOLUTION OF ENZYMATIC MECHANISMS OF RESISTANCE AMONG BETA-LACTAM ANTIBIOTICS

被引:0
作者
GUTMANN, L [1 ]
KITZIS, MD [1 ]
ACAR, JF [1 ]
机构
[1] HOP ST JOSEPH,MED MICROBIOL LAB,F-75674 PARIS 14,FRANCE
关键词
CHROMOSOMAL CEPHALOSPORINASE; BROAD-SPECTRUM PLASMID-MEDIATED BETA-LACTAMASES; ENZYME INHIBITORS; PENICILLIN-BINDING PROTEINS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Resistance to third-generation cephalosporins occurs as a result of either the production of high concentrations of chromosomal cephalosporinase or, increasingly, the presence of broad-spectrum plasmid-mediated beta-lactamases. Both cases represent the response of bacteria in the hospital setting to the selection pressure brought to bear by the use of these antibiotics. Continued evolution of the plasmid-mediated enzymes is occurring as new antibiotics are introduced, probably reflecting the process that began when the first beta-lactamase apparently evolved from the penicillin-binding proteins. beta-Lactamase inhibitors offer one approach to dealing with the evolution of resistance to previously beta-lactamase-stable antibiotics.
引用
收藏
页码:D37 / D47
页数:11
相关论文
共 50 条
[21]   Morphological Deconvolution of Beta-Lactam Polyspecificity in E. coli [J].
Godinez, William J. ;
Chan, Helen ;
Hossain, Imtiaz ;
Li, Cindy ;
Ranjitkar, Srijan ;
Rasper, Dita ;
Simmons, Robert L. ;
Zhang, Xian ;
Feng, Brian Y. .
ACS CHEMICAL BIOLOGY, 2019, 14 (06) :1217-1226
[22]   Translating PK-PD Principles Into Improved Methodology for Clinical Trials That Compare Intermittent With Prolonged Infusion of Beta-Lactam Antibiotics [J].
Tilanus, Alwin M. ;
Shields, Ryan K. ;
Lodise, Thomas P. ;
Drusano, George L. .
CLINICAL INFECTIOUS DISEASES, 2025,
[23]   Beta-Lactam Antibiotics Promote Extracellular Vesicle Production of Staphylococcus aureus Through ROS-Mediated Lipid Metabolic Reprogramming [J].
Huang, Xiaonan ;
Hu, Zhen ;
Shang, Weilong ;
Chen, Juan ;
Hu, Qiwen ;
Zhou, Yumin ;
Ding, Ruolan ;
Yin, Jing ;
Li, Mengyang ;
Liu, He ;
Dou, Jianxiong ;
Peng, Huagang ;
Rao, Yifan ;
Liu, Lu ;
Wang, Yuting ;
Tan, Li ;
Yang, Yuhua ;
Wu, Jianghong ;
Xiao, Chuan ;
Yang, Yi ;
Rao, Xiancai .
JOURNAL OF EXTRACELLULAR VESICLES, 2025, 14 (05)
[25]   Role of inhibition of penicillin binding proteins and cell wall cross-linking by beta-lactam antibiotics in low- and high-level methicillin resistance of Staphylococcus aureus [J].
Higashi, Y ;
Wakabayashi, A ;
Matsumoto, Y ;
Watanabe, Y ;
Ohno, A .
CHEMOTHERAPY, 1999, 45 (01) :37-47
[26]   Molecular mechanisms of β-lactam resistance in Streptococcus pneumoniae [J].
Hakenbeck, Regine ;
Brueckner, Reinhold ;
Denapaite, Dalia ;
Maurer, Patrick .
FUTURE MICROBIOLOGY, 2012, 7 (03) :395-410
[27]   Self-resistance in Streptomyces, with Special Reference to β-Lactam Antibiotics [J].
Ogawara, Hiroshi .
MOLECULES, 2016, 21 (05)
[28]   Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit? [J].
Rahme, Christine ;
Butterfield, Jill M. ;
Nicasio, Anthony M. ;
Lodise, Thomas P. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 80 (04) :239-259
[29]   COMBINATION BETA-LACTAM AND BETA-LACTAMASE-INHIBITOR PRODUCTS - ANTIMICROBIAL ACTIVITY AND EFFICIENCY OF ENZYME-INHIBITION [J].
ROTSCHAFER, JC ;
OSTERGAARD, BE .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (06) :S15-S22
[30]   Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis [J].
Wivagg, Carl N. ;
Bhattacharyya, Roby P. ;
Hung, Deborah T. .
JOURNAL OF ANTIBIOTICS, 2014, 67 (09) :645-654